Clinical trial
Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus…
NCT00121914 · Medical University of Vienna, Other · Unknown status
Key facts
| NCT number | NCT00121914 |
|---|---|
| Title | Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone |
| Official title | Treatment of Hepatocellular Carcinoma: A Randomized Controlled Study With Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma, Hepatocellular |
| Intervention type | Procedure |
| Interventions | percutaneous ethanol instillation (PEI) |
| Enrollment | 120 |
| Start date | Oct 1, 2000 |
| Completion | Jul 1, 2005 |
| First posted | Jul 21, 2005 |
| Last update posted | Oct 18, 2005 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: